Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat...
46 KB (3,654 words) - 04:29, 18 December 2024
PANORAMIC trial (section Molnupiravir)
were molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid). Results from the trial showed that for higher risk, vaccinated adults molnupiravir does...
12 KB (1,087 words) - 03:59, 25 November 2024
the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along...
7 KB (510 words) - 13:44, 12 November 2024
COVID-19 drug development (section Molnupiravir)
molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID‑19 pandemic. In September 2023, molnupiravir's vial...
90 KB (13,197 words) - 04:28, 26 July 2024
include molnupiravir, high-dose nitazoxanide, the monoclonal antibody Vir 7832, intravenous favipiravir, and the combination of molnupiravir plus nirmatrelvir/ritonavir...
8 KB (878 words) - 05:24, 13 July 2024
Feline infectious peritonitis (section Molnupiravir)
of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline...
26 KB (2,894 words) - 14:03, 26 December 2024
in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19...
6 KB (547 words) - 14:35, 30 October 2023
adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
368 KB (32,718 words) - 17:52, 31 December 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
67 KB (6,361 words) - 23:43, 27 October 2024
being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
288 KB (33,190 words) - 07:03, 5 January 2025
health and nutrition products including the oral anti covid medication Molnupiravir & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir....
4 KB (256 words) - 13:52, 6 June 2024
revealed that private firm MERCK was the sole importer of anti-COVID drugs Molnupiravir and Ronapreve on the island of Mauritius. Kailesh Jagutpal further revealed...
20 KB (2,165 words) - 11:21, 7 December 2024
Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl nitrite Isopentyl...
26 KB (1,722 words) - 09:50, 2 November 2024
HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 Merck & Co. viral RNA polymerase inhibitor Moroxydine Influenza...
13 KB (513 words) - 00:20, 23 November 2024
(~380 patients × 2) clinical trial launched a year ago reports that molnupiravir substantially reduced the risk of hospitalization (7.3% to 14.1%) and...
299 KB (38,958 words) - 21:53, 29 December 2024
treat millions of people in countries such as Yemen and African nations. Molnupiravir is an antiviral pill to treat COVID-19, developed in partnership with...
99 KB (9,737 words) - 17:44, 3 January 2025
and maintaining oversight of critical decisions. Molnupiravir Scandal The core issue in the Molnupiravir scandal in Mauritius around December 2021 was the...
47 KB (4,470 words) - 04:03, 4 January 2025
COVID-19 antivirals including paxlovid (nirmatrelvir/ritonavir) and molnupiravir on acute COVID-19 outcomes and long COVID. Including work which evaluated...
15 KB (1,483 words) - 04:05, 29 November 2024
(SARS-CoV-2) Coronaviridae droplet contact coronavirus disease 2019 (COVID-19) Molnupiravir, Nirmatrelvir/ritonavir hand washing covering mouth when coughing or...
36 KB (1,249 words) - 10:35, 10 July 2024
Government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. The Malaysian Deputy Education Minister...
25 KB (1,875 words) - 06:47, 20 November 2024
government unit in the country to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
184 KB (16,120 words) - 13:30, 1 January 2025
in the UK: The UK becomes the first country in the world to approve molnupiravir, an oral antiviral pill for COVID-19 that cuts the risk of hospitalisation...
347 KB (33,564 words) - 12:35, 2 January 2025
Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Remdesivir Co-packaged Nirmatrelvir ritonavir...
180 KB (23,898 words) - 14:59, 19 August 2024
additional federal funding to Ridgeback Biotherapeutics to further develop molnupiravir into a treatment for COVID-19. He argued that although the drug had shown...
31 KB (2,760 words) - 15:59, 28 December 2024
speed of classical supercomputers. Scientists report that repurposed Molnupiravir can completely suppress SARS-CoV-2 transmission within 24 hours in ferrets...
152 KB (27,272 words) - 16:36, 5 October 2024
Merck Sharp & Dohme (MSD) to purchase the experimental antiviral pill molnupiravir. If approved by Medsafe, Pharmac will be supplied with 60,000 courses...
266 KB (17,612 words) - 22:31, 30 December 2024
of the replication inhibition of the corona virus by Remdesivir and Molnupiravir 2004 Roche Symposium Award (Leading chemists of the next decade), Basel...
9 KB (984 words) - 04:00, 24 November 2024
marketing authorisation, to Promomed, for Esperavir, a drug based on molnupiravir and developed for the treatment of COVID-19. In April 2022, Ministry...
17 KB (1,269 words) - 09:55, 6 May 2024
government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. Under the Movement Control Order put in...
221 KB (16,305 words) - 11:13, 31 December 2024
for vulnerable patients to obtain a range of drugs including paxlovid, molnupiravir, and remdesivir. Timeline of the COVID-19 pandemic in July 2022 Responses...
3 KB (200 words) - 23:00, 28 August 2024